Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally. The company operates through Cell Therapies, Developing New Anti-Cancer Drugs, Detection & Diagnosis of Infectious Diseases, and e-commerce Platform for Pharmaceutical and Healthcare Products segments. It also offers NicoBloc, a smoking cessation/harm reduction product; and fogibloc air purifier, olansi water filter, health supplements, cosmetic products, and viral diagnostic kits. In addition, the company provides cosmetic products, such as moisturizing silk mask, and silk mask treatment, Odd Beroni AGG skin rejuvenation, skin repair, and wrinkle care facial masks; and offers SARS-CoV-2 antibody and antigen detection kits, as well as offers CII-ArboViroPlex rRT-PCR assay, a diagnostic kit used to detect viruses such as Zika, Dengue, Chikungunya, and West Nile. Further, it engages in the research and development of anti-cancer drugs and cell therapies; provision of e-commerce platform for pharmaceutical and healthcare products; and detection and diagnosis of infectious diseases. Additionally, the company offers tablet candy and freeze-dried powder juice, as well as provides technical advisory services. Beroni Group Limited was founded in 2014 and is based in Sydney, Australia.